Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis

Melville, AR, Yusof, Y, Fitton, J orcid.org/0000-0002-7795-8191 et al. (6 more authors) (2021) Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis. Rheumatology. ISSN 1462-0324

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an author produced version of a journal article published in Rheumatology. Uploaded in accordance with the publisher's self-archiving policy.

Keywords: rheumatoid arthritis; b-lymphocytes; antirheumatic drugs, disease-modifying; comorbidity; follow-up; rituximab; biosimilar pharmaceuticals
Dates:
  • Published (online): 12 January 2021
  • Accepted: 14 November 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 01 Dec 2020 13:02
Last Modified: 12 Jan 2022 01:38
Status: Published online
Publisher: Oxford University Press
Identification Number: 10.1093/rheumatology/keaa834
Open Archives Initiative ID (OAI ID):

Export

Statistics